KR100904859B1 - The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. bora valley - Google Patents
The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. bora valley Download PDFInfo
- Publication number
- KR100904859B1 KR100904859B1 KR1020080013231A KR20080013231A KR100904859B1 KR 100904859 B1 KR100904859 B1 KR 100904859B1 KR 1020080013231 A KR1020080013231 A KR 1020080013231A KR 20080013231 A KR20080013231 A KR 20080013231A KR 100904859 B1 KR100904859 B1 KR 100904859B1
- Authority
- KR
- South Korea
- Prior art keywords
- bora valley
- potato
- starch
- juice
- bora
- Prior art date
Links
- 244000061456 Solanum tuberosum Species 0.000 title claims abstract description 87
- 235000002595 Solanum tuberosum Nutrition 0.000 title claims abstract description 87
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 24
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 23
- 201000005917 gastric ulcer Diseases 0.000 title claims abstract description 23
- 208000000718 duodenal ulcer Diseases 0.000 title claims abstract description 17
- 235000013305 food Nutrition 0.000 title description 10
- 210000002784 stomach Anatomy 0.000 title description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 34
- 229920002472 Starch Polymers 0.000 claims abstract description 21
- 239000008107 starch Substances 0.000 claims abstract description 21
- 235000019698 starch Nutrition 0.000 claims abstract description 21
- 229920001592 potato starch Polymers 0.000 claims abstract description 20
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 239000006187 pill Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 235000013376 functional food Nutrition 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 235000015872 dietary supplement Nutrition 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 5
- 239000007902 hard capsule Substances 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 239000012669 liquid formulation Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract 5
- 239000007903 gelatin capsule Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 235000012015 potatoes Nutrition 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 5
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- 229960000381 omeprazole Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- -1 15mg Chemical compound 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 229960002986 dinoprostone Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 235000004976 Solanum vernei Nutrition 0.000 description 1
- 241000352057 Solanum vernei Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- YXJHJCDOUFKMBG-BMZHGHOISA-M riboflavin sodium Chemical compound [Na+].OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)[N-]C2=O YXJHJCDOUFKMBG-BMZHGHOISA-M 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 229940056069 zinc oxide 15 mg Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 감자의 신품종인 보라밸리 감자(Solanum tuberosum L., cv. Bora valley)의 생즙 또는 전분을 함유하며, 위염, 위궤양 및 십이지장궤양의 예방 또는 개선 기능을 갖는 건강기능식품에 관한 것이다.The present invention relates to a dietary supplement containing fresh juice or starch of a new kind of potato, Solanum tuberosum L., cv.Bora valley, and having a function of preventing or improving gastritis, gastric ulcer and duodenal ulcer.
감자는 남미 안데스지방이 원산지로서 구황작물로 유용한 작물이다. 감자는 생육기간이 짧고 단위 면적 당 생산량이 비교적 높고 환경적응성도 비교적 강하기 때문에 세계 130여개 나라에서 재배되고 있는 벼, 밀가루, 옥수수 다음으로 가는 세계 4대 식량작물 중의 하나이다. 감자는 쌀과 보리 같은 다른 작물에 비해 저 칼로리면서 비타민 C, B1, B2, 니아신 등의 영양소가 거의 채소에 가깝다. 따라서 감자의 일반적인 영양학적인 분석과, 항산화활성과 같은 생리활성에 대한 연구들이 많이 되었다. 세계적인 감자생산 면적은 저 개발국가를 중심으로 매년 증가 추세에 있다. Potatoes are native to the Andes of South America and are useful crops for coarse grain crops. Potatoes are one of the four largest food crops next to rice, wheat and corn, which are grown in more than 130 countries because of their short growing period, relatively high yields per unit area, and relatively high environmental adaptability. Potatoes are low-calorie compared to other crops such as rice and barley, and have almost the same nutrients as vitamins C, B 1 , B 2 , and niacin. Therefore, there have been many studies on the general nutritional analysis of potatoes and the biological activities such as antioxidant activity. The global potato production area is increasing every year, especially in less developed countries.
최근의 국제농업환경의 변화로 식량전쟁 또는 종자전쟁에 대한 압박이 더욱더 가해지고 있으며, 식량이 미래의 무기가 될 것이기 때문에 각국은 식량작물과 관련된 품종권 보호에 총력을 기울이고 있는 상황이다. 한국 또한 2002년에 국제식물신품종 보호연맹인 UPOV 에 가입하였고, 품종보호기간도 국가별로 약간씩 다르지만 최소 18년에서 35년에 걸친 품종보호 제도가 법제화 되었다. 이러한 상황에서 본 발명자들은 다양한 기능성 감자 신품종 개발하여 국가 품종으로 등록(국립종자관리원, 신품종 15종 및 출원 4 품종)하고 외국 감자 품종들(수미/미국품종 Superior, 대지/일본품종 大地, 대서/미국품종 Atlantic)을 대체하고 있을 뿐만 아니라, 미국, 캐나다, 프랑스, 러시아, 몽골, 중국, 카자스탄, 인도 등지에서 시험재배를 진행시키고 있다. Recent changes in the international agricultural environment are putting increasing pressure on food wars and seed wars, and countries are focusing their efforts on protecting crop rights in relation to food crops because food will become the weapon of the future. Korea also joined UPOV, a new plant protection international federation in 2002, and the protection period for varieties varies slightly from country to country, but at least 18 to 35 years have been enacted. In this situation, the inventors developed various functional potato varieties and registered as national varieties (National Seed Service, 15 new varieties and 4 varieties of application), and foreign potato varieties (Sumi and American varieties Superior, Motherland and Japanese varieties 大地, Atlantic / USA In addition to replacing the cultivar Atlantic, they are also undergoing trial cultivation in the United States, Canada, France, Russia, Mongolia, China, Kazakhstan and India.
감자는 일부 국가에서는 주식으로서도 중요할 뿐 만 아니라, 다양한 가공제품을 만드는데 이용 되기도 하고, 음식문화가 서구화 됨에 따라서 감자의 소비는 더 한층 증가하는 추세에 있다. 이러한 소비 증가에 따라서 좀더 건강지향적인 감자 품종의 개발이 필요하게 되었다. Potatoes are not only important as stocks in some countries, they are also used to make a variety of processed products, and the consumption of potatoes is on the rise as the food culture becomes westernized. This increase in consumption necessitates the development of healthier potato varieties.
감자는 민간에서 많은 종류의 질환에 유용하게 사용되고 있는 것으로 전해진 다. 대한민국 공개특허공보 제2001-29185호에는 감자가 고혈압, 심장병, 변비증, 간염 및 기타 미생물을 억제하여 항박테리아 작용, 항암작용이 있음을 기재하고 있으나, 그 효능에 대하여는 전혀 알 수 없다.Potatoes are reported to be useful in many types of diseases in the private sector. Korean Laid-Open Patent Publication No. 2001-29185 discloses that potato has antibacterial and anticancer effects by inhibiting hypertension, heart disease, constipation, hepatitis and other microorganisms, but its efficacy is not known at all.
본 발명자들은 감자를 개량하여 신품종 감자를 개발한 바 있으며, 본 발명자들에 의하여 개발된 신품종 감자는 각각의 신품종마다 그 효능을 달리하고 있다. 즉, 대한민국 등록특허공보 제628417호에 신품종 밸리감자(보라밸리, 쥬스밸리, 다솜밸리, 고구밸리)가 인체 장기능 강화에 효능이 있음이 공지되어 있으며, 대한민국 등록특허공보 제654231호에는 고구밸리 품종의 감자(Solanum tuberosum L cv. Gogu Valley)에서 분리된 펩타이드가 항균작용이 탁월한 것이 공지되어 있고, 대한민국 등록특허공보 제654232호에는 골든밸리 품종의 감자(Solanum tuberosum L cv. Golden Valley)에서 분리된 펩타이드가 항균작용이 우수한 것이 공지되어 있다. 또한 대한민국 등록특허공보 제583192호에는 보라밸리 품종의 감자(Solanum tuberosum L., cv Bora valley) 추출물의 항산화제가 개시되어 있으며, 대한민국 등록특허공보 제709238호에는 보라밸리 감자(Solanum tuberosum L., cv Bora valley)의 에탄올 추출물이 비만세포가 분화되는 것을 차단하고 비만세포로 분화하는 렙틴(leptin) 단백질을 감소시킴으로써 비만억제 작용을 갖는다는 것이 공지되어 있다.The present inventors have developed new varieties of potatoes by improving potatoes, and the new varieties of potatoes developed by the present inventors have different efficacy for each new varieties. In other words, Korea Patent Publication No. 628417 is known that the new varieties Valley Potato (Bora Valley, Juice Valley, Dasom Valley, Gogu Valley) is effective in strengthening the human long-term function, Republic of Korea Patent Publication No. 654231 Peptides isolated from potato varieties ( Solanum tuberosum L cv. Gogu Valley) are known to have excellent antimicrobial activity, and Korean Patent Publication No. 654232 discloses potato from Solanum tuberosum L cv. Golden Valley. It is known that the peptide is excellent in antibacterial action. In addition, Korean Patent Publication No. 583192 discloses an antioxidant of Borlan valley varieties Potato ( Solanum tuberosum L., cv Bora valley) extract, Republic of Korea Patent No. 709238, Solanum tuberosum L., cv It is known that ethanol extract of Bora valley has an anti-obesity effect by blocking mast cells from differentiating and reducing leptin protein that differentiates into mast cells.
본 발명에 따른 보라밸리 감자(Solanum tuberosum L., cv Bora valley)는 본 발명자에 의해 개발된 속살까지 보라색이며, 보라색 감자 칩을 위한 가공용 감자 신품종으로, 국립종자관리원에 품종보호출원(출원번호:2002-11)해서 2004년에 국가품종으로 등록(등록번호:1-5-2004-5)이 되었다. 이 품종은 A87spx14-4를 모본으로 하고 gurmeys purple를 부본으로 1996년에 유전자 조작 방법이 아닌 인공 교배법으로 진정종자를 획득 한 후 1997년 봄, 가을 두 번 걸쳐 실생 양성을 실시하였다. 1998년에 본 검정 및 1999-2001년에 생산력 검정시험과 지역적응성 시험(춘천서면, 김제광활면, 대관령횡계 등)을 실시하였다. 지역적응성 시험은 봄, 여름, 가을, 겨울하우스 재배 지역에서 실시하였다. 2002년에 신품종 권리보호 출원을 했고, 국립종자관리원에서는 2년간 3곳의 국가연구기관에 의뢰해서 검증을 거친 후 신품종의 우수성을 인정해서 2004년 국내 최초로 보라색 감자칩 가공용 품종이 탄생하게 되었다. 본 품종은 광택이 나는 자주색 표피와 짙은 자주색 육색으로 다양한 요리와 식품개발에의 응용 가능성을 보여 왔다. 보라밸리 감자는 2007년 모스코바에서 개최된 국제감자박람회에서 혁신상 부문에서 최고상인 금상을 수상한 세계적으로 인정받고 있는 감자 품종이다. Boran valley potato ( Solanum tuberosum L., cv Bora valley) according to the present invention is purple until the flesh developed by the present inventors, a new potato for processing for purple potato chips, varieties protection application (application number: 2002-11) was registered as a national breed in 2004 (registration number: 1-5-2004-5). The cultivars used A87spx14-4 as a model and gurmeys purple as a copy, and obtained real seed by artificial breeding method in 1996, not genetically modified. This test was conducted in 1998 and the productivity test and the adaptability test (Chuncheon Seomyeon, Gimje Gwangsaengmyeon, Daegwallyeong Transverse, etc.) in 1999-2001. The adaptability test was conducted in spring, summer, autumn and winter house growing areas. In 2002, a new varieties of rights protection application was filed, and the National Seed Management Service was commissioned by three national research institutes for two years and verified. The varieties have a glossy purple cuticle and dark purple flesh, which have been shown to be applicable to various dishes and food development. Bora Valley Potatoes are a globally recognized potato variety that won the Gold Prize in the Innovation Awards at the 2007 International Potato Fair in Moscow.
본 발명자들은 우리나라의 오랜 민간요법 중에는 감자를 생으로 먹으면 위염 및 장염에 효과가 우수하다고 구전되어 오고 있음에 착안하여 상기 신품종 감자인 보라밸리 감자(Solanum tuberosum L., cv Bora valley)의 건강기능식품으로서의 용도를 연구하던 중에 일반감자는 구전되어 오던 효능과는 달리 위염, 위궤양 및 십이지장궤양에 하등의 활성을 보이지 않고, 오히려 보라밸리 감자의 생즙 및 전분이 위염, 위궤양 및 십이지장궤양에 탁월한 작용을 나타냄을 확인하고 본 발명을 완성하였다.The present inventors have been taught that the long-term folk remedies in Korea have been said to have an excellent effect on gastritis and enteritis when eaten raw potatoes as a health functional food of the new varieties potato, Solanum tuberosum L., cv Bora valley. Unlike the efficacy that has been orally used during research, the general potato does not show any activity on gastritis, gastric ulcer and duodenal ulcer. It confirmed and completed this invention.
본 발명은 감자의 신품종인 보라밸리 감자(Solanum tuberosum L., cv Bora valley)를 이용하여 위염, 위궤양 및 십이지장궤양을 예방 및 개선할 수 있는 건강기능식품을 제공하는 것을 목적으로 한다.An object of the present invention to provide a health functional food that can prevent and improve gastritis, gastric ulcer and duodenal ulcer by using a new varieties of potatoes, Solanum tuberosum L., cv Bora valley.
상기 목적을 달성하기 위하여, 본 발명은 보라밸리 감자(Solanum tuberosum L., cv Bora valley)의 생즙 또는 전분을 함유함으로써 위염, 위궤양 및 십이지장궤양을 예방 및 개선할 수 있는 건강기능식품을 제공한다.In order to achieve the above object, the present invention provides a health functional food that can prevent and improve gastritis, gastric ulcer and duodenal ulcer by containing the juice or starch of Boran valley potato ( Solanum tuberosum L., cv Bora valley).
본 발명은 보라밸리 감자(Solanum tuberosum L., cv. Bora valley)의 싹 부위를 제거한 후 쥬서기를 이용하여 생즙을 제조할 수 있다.The present invention can be prepared using a juicer after removing the shoot portion of the Bora valley potato ( Solanum tuberosum L., cv. Bora valley).
또한, 본 발명에 의한 보라밸리 감자 전분은 상기 보라밸리 감자 생즙을 상온에서 10분 방치한 후 감압 여과하여 보라밸리 감자 전분층과 여액으로 분리 한 다음 보라밸리 감자 전분층을 냉동 감압 건조하여 건조전분을 얻거나, 65℃에서 건조하여 건조 감자전분을 얻을 수 있다.In addition, the Bora Valley potato starch according to the present invention is left in the Bora Valley potato juice at room temperature for 10 minutes and then filtered under reduced pressure to separate the Bora Valley potato starch layer and the filtrate and dried under reduced pressure drying the Bora Valley potato starch layer and dried starch Or dried at 65 ° C. to obtain dried potato starch.
그리고 본 발명은 보라밸리 감자의 생즙 또는 전분을 통상적인 기호성 식품 즉, 라면, 생면 등의 면류, 두부, 시리얼, 빵류, 츄잉 껌, 사탕, 과자류 중에 첨가하여 통상적으로 알려진 방법에 의하여 각종 식품을 제조할 수 있고, 또한 산제, 정제, 과립제, 환제, 경질캅셀제, 연질캅셀제 또는 액제 제형 등 일반적인 제형으로 제형화 될 수 있으며, 생즙, 파우치, 음료, 또는 다류로 제조될 수 있고, 상기한 성분 이외에 다른 성분은 제형에 따라 당업자가 적의하게 선택하여 배합 할 수 있다.And the present invention is added to the juice or starch of Bora Valley potato in the usual palatable foods, such as ramen noodles, raw noodles, noodles, tofu, cereals, breads, chewing gum, candy, confectionery to produce a variety of food by a commonly known method Can also be used in powders, tablets, granules, It may be formulated into a general formulation such as pills, hard capsules, soft capsules, or liquid formulations, and may be prepared in juice, pouches, beverages, or polysaccharides. You can mix.
본 발명의 위염, 위궤양 및 십이지장궤양을 예방 및 개선할 수 있는 건강기능식품은 상기 보라밸리 감자(Solanum tuberosum L., cv. Bora valley) 생즙 또는 전분을 식품의 주· 부원료로 하여 제조되거나 다른 식품에 첨가됨으로서 제조될 수 있다. 이 때 식품학적으로 허용되는 식품보조첨가제를 사용할 수 있다.Health functional foods that can prevent and improve gastritis, gastric ulcer and duodenal ulcer of the present invention is prepared by using the Bora valley potato ( Solanum tuberosum L., cv. It can be prepared by adding to. At this time, food supplements that can be used food acceptable.
본 발명의 보라밸리 감자(Solanum tuberosum L., cv. Bora valley) 생즙 또는 전분에 관한 에탄올 유도 랫드 위궤양 모델에서의 시험은 위궤양 예방 및 치료제로 시판되고 있는 오메프라졸 제제보다 오히려 예방 효과가 우수한 효과가 있음을 보여주었다. Solanum tuberosum L., cv. Bora valley of the present invention, the test in ethanol-induced rat gastric ulcer model of the juice or starch has a superior preventive effect than the omeprazole formulation commercially available for the prevention and treatment of gastric ulcer Showed.
또한 본 발명은 보라밸리 감자의 생즙 또는 전분에 관한 위염모델의 PGE 2 측정시험에서 유의적인 억제율을 나타내므로 이를 함유한 건강기능식품은 위염, 위궤양 및 십이지장궤양을 예방 및 개선에 유용하게 이용될 수 있다.In addition, the present invention shows a significant inhibition rate in the PGE 2 measurement test of gastritis model of the juice or starch of Bora Valley potato, so the health functional food containing it can be usefully used to prevent and improve gastritis, gastric ulcer and duodenal ulcer have.
그러므로 본 발명의 보라밸리 감자(Solanum tuberosum L., cv. Bora valley) 생즙 또는 전분은 위염, 위궤양 및 십이지장궤양 환자를 위한 새로운 건강기능식품의 소재로서 위염, 위궤양 및 십이지장궤양의 예방 및 개선을 위한 건강기능식품으로 개발될 수 있다.Therefore, the raw juice or starch of Solanum tuberosum L., cv.Bora valley of the present invention is a novel dietary supplement for patients with gastritis, gastric ulcer and duodenal ulcer and for preventing and improving gastritis, gastric ulcer and duodenal ulcer. Can be developed as a dietary supplement.
본 발명의 보라밸리 감자(Solanum tuberosum L., cv. Bora valley) 생즙 또는 전분은 급성독성시험 결과 식품에 첨가하여 사용하기에 적합한 것이다. Solanum tuberosum L. (cv. Bora valley) juice or starch of the present invention is suitable for use in foods as a result of acute toxicity test.
본 발명은 보라밸리 감자(Solanum tuberosum L., cv Bora valley)의 생즙 또는 전분이 위염, 위궤양 및 십이지장궤양의 예방 및 치료제로 시판되고 있는 오메프라졸 제제와 동등 이상의 위궤양 발생을 억제하며, PGE 2의 양을 유의적으로 억제 작용이 있음을 알 수 있다.The present invention suppresses the occurrence of gastric ulcer that is equal to or higher than the omeprazole preparation marketed as a prophylactic and therapeutic agent for the prevention and treatment of gastritis, gastric ulcer and duodenal ulcer in the juice or starch of Boran valley ( Solanum tuberosum L., cv Bora valley). It can be seen that there is a significant inhibitory action.
그러므로 본 발명은 위염, 위궤양 및 십이지장궤양의 예방 및 개선을 위한 건강기능식품으로 유용하게 이용될 수 있다.Therefore, the present invention can be usefully used as a dietary supplement for the prevention and improvement of gastritis, gastric ulcer and duodenal ulcer.
이하에서는 본 발명의 실시예를 통해 본 발명을 더욱 상세히 설명한다. 하기 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 내용이 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. The following examples are intended to illustrate the invention and are not intended to limit the scope of the invention.
<실시예 1> <Example 1> 보라밸리 감자 생즙의 제조Preparation of Bora Valley Potato Juice
보라밸리 감자(Solanum tuberosum L., cv. Bora valley) 55 g을 잘 씻고 싹 부위를 제거한 후 쥬서기를 이용하여 생즙 약 50 ml의 보라밸리 감자 생즙을 얻었다. Solanum tuberosum L., cv. Bora valley (55 g) was washed well, the shoots were removed, and juice juicers were used to obtain approximately 50 ml of Bora Valley potato juice.
<실시예 2> <Example 2> 보라밸리 감자 전분의 제조Preparation of Bora Valley Potato Starch
상기 실시예 1에서 제조된 보라밸리 감자 생즙 40ml을 상온에서 10분 방치한 후 감압 여과하여 보라밸리 감자 전분층과 여액으로 분리 한 다음 보라밸리 감자 전분층을 65℃에서 건조하여 6.4g의 건조 감자전분을 얻었다.40 ml of the Bora Valley potato juice prepared in Example 1 was left at room temperature for 10 minutes, filtered under reduced pressure, separated into a Bora Valley potato starch layer and a filtrate, and the Bora Valley potato starch layer was dried at 65 ° C. to dry 6.4 g of potato chips. Got minutes.
<실시예 3> <Example 3> 보라밸리 감자 전분의 제조Preparation of Bora Valley Potato Starch
상기 실시예 1에서 제조된 보라밸리 감자 생즙 40ml을 상온에서 10분 방치한 후 감압 여과하여 보라밸리 감자 전분층과 여액으로 분리 한 다음 보라밸리 감자 전분층을 냉동 감압 건조하여 건조 감자전분 7.4g을 얻었다.40 ml of the Bora Valley potato juice prepared in Example 1 was left at room temperature for 10 minutes and filtered under reduced pressure to separate the Bora Valley potato starch layer and the filtrate. The Bora Valley potato starch layer was dried under reduced pressure and freeze dried potato starch 7.4 g. Got it.
<비교예 1> Comparative Example 1 일반 감자 생즙의 제조Preparation of Plain Potato Juice
일반 감자 55 g을 실시예 1과 동일한 방법으로 제조하여 생즙 약 31 ml의 일 반 감자 생즙을 얻었다.55 g of ordinary potatoes were prepared in the same manner as in Example 1, to obtain about 31 ml of raw potato juice.
<비교예 2> Comparative Example 2 일반 감자 전분의 제조Preparation of Plain Potato Starch
비교예 1에서 제조된 일반 감자 생즙 30 ml을 실시예 2와 동일한 방법으로 제조하여 8.8 g의 건조 감자전분을 얻었다.30 ml of normal potato juice prepared in Comparative Example 1 was prepared in the same manner as in Example 2 to obtain 8.8 g of dried potato starch.
<실험예 1> Experimental Example 1 Ethanol 유도 rat 위궤양 모델에서의 감자의 저해능 측정Inhibition of Potatoes in Ethanol-induced Rat Gastric Ulcer Model
실시예 1, 2 및 비교예 1, 2에서 제조된 감자 생즙 0.5 ml 및 및 감자 전분 10 mg씩을 각각 0.1% CMC에 녹여 SD rat(male, SPF, 150 - 200 g, 오리엔트바이오사로부터 구입)에 경구투여 하였다. 그 후 위궤양을 유도하기 위하여 Rao등의 방법(J. Ethnopharmacol. 91, 243, 2004)에 따라, 1시간 후 ethanol을 경구 투여한 다음 4시간 경과 후 rat를 sacrifice하고 위를 절제한 후 formalin에 고정하고 궤양의 넓이를 측정하고 그 결과를 표 1에 나타내었다. 대조군으로는 오메프라졸 5 mg을 사용하였다.0.5 ml of potato juice prepared in Examples 1 and 2 and Comparative Examples 1 and 2, and 10 mg of potato starch, respectively, were dissolved in 0.1% CMC in SD rats (male, SPF, 150-200 g, purchased from Orient Bio Company). Oral administration. Then, in order to induce gastric ulcers, according to the method of Rao et al. (J. Ethnopharmacol. 91, 243, 2004), ethanol was orally administered after 1 hour, sacrificed rats after 4 hours, and excised stomach was fixed in formalin. The area of ulcer was measured and the results are shown in Table 1. 5 mg of omeprazole was used as a control.
표 1에서 알 수 있는 바와 같이, 본 발명에 의한 실시예 1 및 실시예 2는 위궤양 예방 및 치료제로 시판되고 있는 오메프라졸과의 비교시험에서 동등 이상의 위궤양 억제 효과를 나타내었음을 알 수 있다.As can be seen from Table 1, it can be seen that Example 1 and Example 2 according to the present invention showed more than equivalent gastric ulcer inhibitory effect in the comparison test with omeprazole commercially available for the prevention and treatment of gastric ulcer.
그러나, 일반 감자인 비교예 1 및 비교예 2(수미, Superior, 미국)는 구전되어 오고 있는 위염 등의 효과와는 달리 거의 효과를 나타내지 못함을 알 수 있다.However, it can be seen that Comparative Examples 1 and 2 (Sumi, Superior, USA), which are ordinary potatoes, show little effect unlike the effects of gastritis, which have been orally transmitted.
그러므로 신품종인 보라밸리 감자(Solanum tuberosum L., cv. Bora valley)의 생즙 또는 전분은 일반 감자와는 달리 위염, 위궤양 및 십이지장궤양에 매우 효과가 뛰어난 것임을 확인 할 수 있다.Therefore, the fresh juice or starch of the new varieties Boran valley ( Solanum tuberosum L., cv. Bora valley) is very effective in gastritis, gastric ulcer and duodenal ulcer, unlike ordinary potatoes.
<실험예 2> Experimental Example 2 위염모델에서의 저해능Inhibitory Activity in Gastritis Model
실시예 1, 3 및 비교예 1, 2에서 제조된 감자 생즙 0.5 ml 및 감자 전분 10 mg씩을 각각 0.1% CMC에 녹여 SD rat(male, SPF, 150 - 200 g, 오리엔트바이오사로부터 구입)에 경구투여 하였다. 1시간 후에 indomethacin을 10 mg/rat의 용량으로 SD rat에 경구 투여하였다. 5시간 후 위부분을 절제하고 polytron homogenizer로 갈고, 원심분리하여 상등액을 얻었다. 이후 ethyl acetate로 추출하고 건조하였다. 이 후 methanol에 녹인 후 Park등의 방법으로(Eur. J. Pharmacol. 425, 153-157, 2001) Sep-Pak C18 column에 넣고 유출한 후 N2로 건조한 후 ELISA 법으로 위의 염증의 parameter인 PGE 2의 양을 정량하고 그 결과를 표 2에 나타내었다.0.5 ml of potato juice and 10 mg of potato starch prepared in Examples 1 and 3 and Comparative Examples 1 and 2, respectively, were dissolved in 0.1% CMC and orally in SD rats (male, SPF, 150-200 g, purchased from Orient Bio Company). Administered. After 1 hour, indomethacin was orally administered to SD rats at a dose of 10 mg / rat. After 5 hours, the stomach was excised, ground with a polytron homogenizer, and centrifuged to obtain a supernatant. Then extracted with ethyl acetate and dried. After dissolving in methanol, Park (Eur. J. Pharmacol. 425, 153-157, 2001), put into Sep-Pak C18 column, and drained, dried with N2, and then PGE which is a parameter of gastric inflammation by ELISA method. The amount of 2 was quantified and the results are shown in Table 2.
표 2에서 알 수 있는 바와 같이, 본 발명에 의한 실시예 1 및 실시예 3은 PGE2 억제 작용이 매우 뛰어나지만, 일반 감자인 비교예 1 및 비교예 2는 구전되어 오고 있는 위염 등의 효과와는 달리 거의 PGE2 억제 효과를 나타내지 못함을 확인할 수 있다.As can be seen from Table 2, Example 1 and Example 3 according to the present invention is very excellent in inhibiting the PGE2, but Comparative Example 1 and Comparative Example 2, which is a regular potato, is different from the effect of gastritis, etc. In contrast, it can be seen that almost no PGE2 inhibitory effect.
그러므로 신품종인 보라밸리 감자(Solanum tuberosum L., cv. Bora valley)의 생즙 또는 전분은 일반 감자와는 달리 위염, 위궤양 및 십이지장궤양에 매우 효과가 뛰어난 것임을 알 수 있다.Therefore, the fresh juice or starch of the new varieties Boran valley ( Solanum tuberosum L., cv. Bora valley) is very effective in gastritis, gastric ulcer and duodenal ulcer, unlike ordinary potatoes.
<실험예 3> Experimental Example 3 급성독성 실험Acute Toxicity Experiment
식약청의 가이드라인에 따라 ICR mouse (male)에 급성독성의 여부를 검정하였다. 그 결과 보라밸리 감자의 생즙은 5.0 ml/kg 까지 어떠한 독성도 발견되지 않았고, 보라밸리 감자의 전분의 경우 750 mg/kg까지 독성이 발견되지 않았다.Acute toxicity was tested for ICR mice (males) according to KFDA guidelines. As a result, the juice of Bora Valley potato did not find any toxicity up to 5.0 ml / kg, and the starch of Bora Valley potato starch was not found up to 750 mg / kg.
이와 같이 보라밸리 감자의 생즙 및 전분의 경우 실제적으로 무독하였으며, 상기의 목적으로 유효한 용량은 생즙의 경우 0.1 - 5 ml/kg에서, 전분의 경우 1 mg - 500 mg/kg으로 사료되며, 1일 1 - 3회 복용이 적당하다.As such, the fresh juice and starch of Bora valley potatoes were practically non-toxic, and the effective dose for this purpose was 0.1-5 ml / kg for fresh juice and 1 mg-500 mg / kg for starch. One to three doses are appropriate.
이러한 안전성 실험을 통하여 본 발명에 따른 보라밸리 감자의 생즙 및 전분 은 인체에 악영향을 미치지 않을 것으로 판단된다.Raw juice and starch of Bora valley potato according to the present invention through this safety test Is not expected to adversely affect the human body.
이하 본 발명에 따른 보라밸리 감자(Solanum tuberosum L., cv Bora valley) 추출물을 츄잉 껌, 라면 등의 면류, 사탕, 과자류, 시리얼, 빵류 등 각종 고상 식품에 첨가하여 위염, 위궤양 또는 십이지장궤양의 예방 및 개선 기능을 갖는 건강기능식품을 제조할 수 있고, 또한 차 및 음료로도 제조할 수 있다. Solanum tuberosum L., cv Bora valley extract according to the present invention is added to various solid foods, such as chewing gum, ramen noodles, candy, confectionery, cereals, breads, etc. to prevent gastritis, gastric ulcer or duodenal ulcer And health functional foods having an improvement function, and may also be produced as tea and beverages.
<제조예 1> 비스켓의 제조Preparation Example 1 Preparation of Biscuits
박력 1급 19.59 중량%, 중력 1급 22.22 중량%, 정백당 4.80 중량%, 식염 0.73 중량%, 포도당 0.78 중량%, 팜쇼트닝 11.15 중량%, 암모 1.54 중량%, 중조 0.17 중량%, 중아황산나트륨 0.16 중량%, 쌀가루 1.45 중량%, 비타민 B1 0.0001 중량%, 비타민 B2 0.0001 중량%, 밀크향 0.04 중량%, 물 21.3298 중량%, 전지분유 1.16 중량%, 대용분유 0.29 중량%, 제일인산칼슘 0.03 중량%, 살포염 0.29 중량% 및 분무유 7.27 중량%와 상기 실시예 2에서 제조된 보라밸리 감자의 건조 분말 7 중량%를 배합하여 통상의 방법으로 비스켓을 제조하였다.Force Grade 1 19.59 wt%, Gravity Grade 1 22.22 wt%, White sugar 4.80 wt%, Salt 0.73 wt%, Glucose 0.78 wt%, Palm shortening 11.15 wt%, Ammo 1.54 wt%, Neutral 0.17 wt%, Sodium bisulfite 0.16 wt% , Rice flour 1.45%, Vitamin B1 0.0001%, Vitamin B2 0.0001%, Milk flavor 0.04%, Water 21.3298%, Whole milk powder 1.16%, Substitute powder 0.29%, calcium phosphate 0.03%, Spray salt Biscuits were prepared in a conventional manner by combining 0.29 wt% and 7.27 wt% of spray oil with 7 wt% of the dry powder of Bora Valley potatoes prepared in Example 2.
<제조예 2> 츄잉 껌의 제조Preparation Example 2 Preparation of Chewing Gum
껌베이스 20 중량%, 설탕 70 중량%, 향료 1 중량% 및 물 2 중량%와 상기 실싱예 2에서 제조된 보라밸리 감자 건조 분말 7 중량%를 배합하여 통상의 방법으로 츄잉껌을 제조하였다.Chewing gum was prepared in a conventional manner by combining 20% by weight of gum base, 70% by weight of sugar, 1% by weight of perfume, and 2% by weight of water, and 7% by weight of Bora Valley potato dry powder prepared in Sealing Example 2.
<제조예 3> 캔디의 제조Preparation Example 3 Preparation of Candy
설탕 50 중량%, 물엿 39.8 량% 및 향료 0.2 중량%와 상기 실시예 2에서 제조된 보라밸리 감자 건조 분말 10 중량%를 배합하여 통상의 방법으로 캔디를 제조하였다.Candy was prepared by the conventional method by combining 50% by weight of sugar, 39.8% by weight of starch syrup, 0.2% by weight of fragrance, and 10% by weight of Bora Valley potato dry powder prepared in Example 2.
<제조예 4> 음료의 제조Preparation Example 4 Preparation of Beverage
꿀 0.26 중량%, 치옥토산아미드 0.0002 중량%, 니코틴산아미드 0.0004 중량%, 염산리보플라빈나트륨 0.0001 중량%, 염산피리독신 0.0001 중량%, 이노시톨 0.001 중량%, 오르트산 0.002 중량% 및 물 89.7362 중량%와 상기 실시예 1에서 제조된 보라밸리 감자 생즙 10 중량%을 배합하여 통상의 방법으로 음료를 제조하였다.0.26% by weight of honey, 0.0002% by weight of thioctoamide, 0.0004% by weight of nicotinic acid, 0.0001% by weight of sodium riboflavinate, 0.0001% by weight of pyridoxine hydrochloride, 0.001% by weight of inositol, 0.002% by weight of orthoic acid and 89.7362% by weight of water Drinks were prepared in a conventional manner by combining 10% by weight of the Bora Valley potato juice prepared in Example 1.
<제조예 5> 정제의 제조Preparation Example 5 Preparation of Tablet
실시예 2에서 제조된 보라밸리 감자 건조 분말 200mg, 비타민 B1 15mg, 비타민 B2 15mg, 비타민 C 25mg, 비타민 B6 25mg, 니코틴산아미드 15mg을 혼합하고, 타블렛의 제형화를 위해 락추로오스 분말 200mg, 실리코알루민산나트륨 25mg, 자당지방산에스테르 25mg, 히드록시프로필메틸셀룰로오스 25mg, 글리세린지방산에스테르 15mg, 산화아연 15mg, 베타-시클로덱스트린 15mg을 첨가한 후 혼합하여 타정기로 정제를 제조하였다.Example 2 See the valley potato dry powder 200mg, vitamin production in B 1 15mg, vitamin B 2, 15mg, Vitamin C 25mg, vitamin B 6 25mg, mixture of nicotinamide 15mg and lock churro agarose powder for formulation of the tablet 200mg Sodium silicoaluminate 25mg, sucrose fatty acid ester 25mg, hydroxypropylmethylcellulose 25mg, glycerin fatty acid ester 15mg, zinc oxide 15mg, beta-cyclodextrin 15mg was added and mixed to prepare a tablet with a tablet press.
<제조예 6> 경질캡슐의 제조Preparation Example 6 Preparation of Hard Capsule
실시예 2에서 제조된 보라밸리 감자 건조 분말 100mg, 비타민 B1 15mg, 비타민 B2 15mg, 비타민 C 25mg, 비타민 B6 25mg, 니코틴산아미드 15mg, 구연산 25mg, 유당 400mg에 정제수 500mg을 혼합하였다. 그 후 상기 혼합물을 과립기에 넣어 과립상으로 성형하고, 상기 성형된 과립을 40~50℃의 열풍건조기에서 건조시킨 후, 12~14 메쉬의 체를 통과시켜 균일한 과립을 제조하였으며, 이를 경질캡슐에 충전하였다.100 mg of Bora Valley potato dry powder prepared in Example 2, vitamin B 1 15 mg, vitamin B 2 15 mg, vitamin C 25 mg, vitamin B 6 25 mg, nicotinic acid amide 15 mg, citric acid 25 mg, lactose 400 mg 500 mg purified water. Thereafter, the mixture was put into a granulator to form granules, and the molded granules were dried in a hot air dryer at 40 to 50 ° C., and then passed through a sieve of 12 to 14 mesh to prepare uniform granules. Charged to.
도 1은 본 발명에 의한 보라밸리 감자(Solanum tuberosum L. cv. Bora valley)의 실물 사진을 나타낸 것이다.1 is a Bora Valley potato ( Solanum) according to the present invention tuberosum L. cv. A real photograph of the Bora valley is shown.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080013231A KR100904859B1 (en) | 2008-02-13 | 2008-02-13 | The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. bora valley |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080013231A KR100904859B1 (en) | 2008-02-13 | 2008-02-13 | The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. bora valley |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100904859B1 true KR100904859B1 (en) | 2009-06-25 |
Family
ID=40983206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080013231A KR100904859B1 (en) | 2008-02-13 | 2008-02-13 | The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. bora valley |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100904859B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2515925A4 (en) * | 2009-12-24 | 2014-05-21 | Univ Mcgill | Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
KR101592450B1 (en) | 2014-03-31 | 2016-02-05 | 소창호 | health functional food for preventing and treating gastritis, gastric ulcer or duodenal ulcer using potato micro-tuber |
US9446063B2 (en) | 2009-12-24 | 2016-09-20 | The Royal Institution For The Advancement Of Learning/Mcgill University | Methods for treating type-2 diabetes and obesity |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6069025A (en) | 1983-07-01 | 1985-04-19 | Zengoro Kikuta | Marvelously effective medicine against stomach cancer |
JP2005206493A (en) * | 2004-01-21 | 2005-08-04 | Unitika Ltd | Anti-helicobacter pylori agent |
KR20050110186A (en) * | 2004-05-18 | 2005-11-23 | (주)포테이토밸리 | Antioxidant containing ferulic acid, caffeic acid, chlorogenic acid or an extract of boravalley potato as an effective ingredient |
KR20060037705A (en) * | 2004-10-28 | 2006-05-03 | (주)포테이토밸리 | Extract having growth-inhibiting and promoting effects of human intestinal bacteria extracted from valley potato cultivars and functional food using the same |
-
2008
- 2008-02-13 KR KR1020080013231A patent/KR100904859B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6069025A (en) | 1983-07-01 | 1985-04-19 | Zengoro Kikuta | Marvelously effective medicine against stomach cancer |
JP2005206493A (en) * | 2004-01-21 | 2005-08-04 | Unitika Ltd | Anti-helicobacter pylori agent |
KR20050110186A (en) * | 2004-05-18 | 2005-11-23 | (주)포테이토밸리 | Antioxidant containing ferulic acid, caffeic acid, chlorogenic acid or an extract of boravalley potato as an effective ingredient |
KR20060037705A (en) * | 2004-10-28 | 2006-05-03 | (주)포테이토밸리 | Extract having growth-inhibiting and promoting effects of human intestinal bacteria extracted from valley potato cultivars and functional food using the same |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2515925A4 (en) * | 2009-12-24 | 2014-05-21 | Univ Mcgill | Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
US9446063B2 (en) | 2009-12-24 | 2016-09-20 | The Royal Institution For The Advancement Of Learning/Mcgill University | Methods for treating type-2 diabetes and obesity |
US9849153B2 (en) | 2009-12-24 | 2017-12-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
KR101592450B1 (en) | 2014-03-31 | 2016-02-05 | 소창호 | health functional food for preventing and treating gastritis, gastric ulcer or duodenal ulcer using potato micro-tuber |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Caluwé et al. | Tamarindus indica L.–A review of traditional uses, phytochemistry and pharmacology | |
KR100709238B1 (en) | The healthy and funtional foods for the obesity patients using purple-colored potato | |
JP5568806B2 (en) | Diabetes or diabetes complication preventive | |
Repo-Carrasco-Valencia | Andean indigenous food crops: nutritional value and bioactive compounds | |
Lebot et al. | The greater yam (Dioscorea alata L.): A review of its phytochemical content and potential for processed products and biofortification | |
JP2017105728A (en) | Hyperglycemic inhibitor and intestinal function-controlling medicine | |
Lim et al. | Colocasia esculenta | |
KR101598395B1 (en) | Method for producing wild plants Kimchi comprising Houttuynia cordata, Saururus chinensis and Momordica charantia | |
KR20240023560A (en) | Composition for anti-inflammation comprising extract from Tartary buckwheat | |
KR100904859B1 (en) | The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. bora valley | |
KR101902932B1 (en) | A composition for preventing, improving or treating alcoholic gastritis of the extracts from the aerial parts except flower and root of Cirsium japonicum and Taraxacum coreanum | |
KR20190033828A (en) | Compositions for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising herbal extracts | |
KR100904862B1 (en) | The healthy and funtional foods for the gastritis, stomach and duodenal ulcer patients using solanum tuberosum l., cv. redking valley | |
KR101478196B1 (en) | Composition for the prevention of foods from oxidation and for retarding the onset of diabetes comprsing of the extract of Cudrania tricuspidata as a main component | |
KR101768612B1 (en) | Food composition for improving liver function and method of health tea using thereof | |
Jat et al. | Bitter Gourd for human health, nutrition, and value addition | |
JP2003252775A (en) | Nk cell activation agent | |
KR100930804B1 (en) | Pharmaceutical composition for the prevention and treatment of gastritis, gastric ulcer and duodenal ulcer containing the juice or starch of bora valley potato as an active ingredient | |
Lim et al. | Fagopyrum esculentum | |
KR102158661B1 (en) | Composition for preventing, ameliorating and treating inflammatory diseases comprising extract of undried immature astrigent persimmon of miyrangbansi as effective component | |
Ravi et al. | Prospects of underutilised taro (Colocasia esculenta) for sustainable biodiversity and nutritional security in India | |
KR20150064521A (en) | Fermented composition comprising bamboo salt and rhynchosia nulubilis | |
KR20180077106A (en) | A composition for improving memory or cognitive function comprising a aurantii fructus immaturus supercritical extract as an active ingredient | |
KR100930809B1 (en) | A pharmaceutical composition for prevention and treatment of gastritis, gastric ulcer and duodenal ulcer comprising red currant powder potato juice or starch as an active ingredient | |
WO2010117093A1 (en) | Functional food using fresh juice or starch made from bora valley potato for patients with gastritis, gastric ulcer or duodenal ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130410 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140320 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160620 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170419 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180619 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190619 Year of fee payment: 11 |